KalVista Pharmaceuticals Aktie
9,20
EUR
-0,15
EUR
-1,60
%
9,63
USD
-0,28
USD
-2,83
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung